Dr. Aditya Bagrodia

Dr. Aditya Bagrodia on the BackTable Podcast

Dr. Aditya Bagrodia


Dr. Aditya Bagrodia is a practicing urologic oncologist and assistant professor at UT southwestern.


Listen to Dr. Bagrodia on the BackTable Urology Podcast

BackTable Urology is a knowledge resource for practicing physicians. Learn from the experiences and expertise of Dr. Aditya Bagrodia and get practical advice on how to build your practice by listening to the BackTable Urology Podcast.

About Dr. Bagrodia

Aditya Bagrodia, M.D., is an Assistant Professor in the Department of Urology at UT Southwestern Medical Center and a host on the BackTable Urology Podcast.

Dr. Bagrodia holds a bachelor of science degree from Rhodes College. While earning a medical degree with highest honors at the University of Tennessee Health Sciences Center, he was awarded a Doris Duke Clinical Research Fellowship at UT Southwestern Medical Center.

After completing his residency in urology at UT Southwestern, he received advanced training in urologic oncology through a fellowship at Memorial Sloan Kettering Cancer Center, where he was awarded a Urology Care Foundation Research Scholars Grant by the American Urological Association.

Dr. Bagrodia’s clinical practice focuses on treating all urologic malignancies, including adrenal, upper tract, renal, bladder, prostate, penile, and testicular cancers. He has expertise in complex multidisciplinary management and minimally invasive approaches to urologic surgery.

Dr. Bagrodia has conducted extensive research in urologic oncology, primarily in biomarker profiles and molecular signatures of urologic tumors as predictors of clinical outcomes. He is funded through competitive grants from the Cancer Prevention and Research Institute of Texas (CPRIT), intramural research grants, and the National Institutes of Health.

Both his clinical practice and research centers on patients with germ cell tumors (most commonly testicular cancer). His laboratory focuses on sequencing efforts to understand tumor evolution and heterogeneity in germ cell tumors and identifying novel biomarkers to recognize occult metastatic disease. The Bagrodia lab also conducts experiments in cell lines, zebrafish germ cell tumor models, and mice to understand the biologic implications of genetic alterations that are seen exclusively among patients with cisplatin-resistance disease. He is actively working on molecular biomarkers to identify minimal residual disease burden. On the clinical side, Dr. Bagrodia is actively involved in understanding and overcoming unique socioepidemiologic considerations that adversely impact oncologic outcomes in patients with germ cell tumors. He is also the principal investigator for several germ cell tumor-directed clinical trials at UT Southwestern (including NCT03426865 and NCT02537548).

Dr. Bagrodia is the principal author or co-author of more than 100 articles in peer-reviewed publications such as Journal of Clinical Oncology, Nature Genetics, European Urology, Journal of Urology, Urologic Oncology, and Urology. He is also a reviewer for many of these publications, as well as for the British Journal of Urology, Journal of Clinical Pathology, and Annals of Surgical Oncology.

Learn more about Dr. Aditya Bagrodia by visiting his practice's website:

Podcasts Featuring Dr. Bagrodia

Ep. 16

Management of Localized Prostate Cancer

We talk with Dr. Jeff Cadeddu about workup and treatment options for patients with localized prostate cancer


Ep. 13

Tips & Tricks for Difficult Ureteroscopy

UT Southwestern Endourologist Dr. Jodi Antonelli shares her tips and tricks for difficult ureteroscopy cases.


Ep. 11

Evaluation & Management of Post-Prostatectomy Incontinence

Dr. Aditya Bagrodia interviews urologist Dr. Steve Hudak from UT Southwestern Medical Center about post-prostatectomy incontinence.


Ep. 10

Management of Locally Advanced Kidney Cancer

Dr. Aditya Bagrodia interviews Dr. Vitaly Margulis, professor of urology at UT Southwestern Medical Center, about locally advanced kidney cancer. They discuss various topics including disease classification, imaging modalities, drug therapies, and nephrectomies.


Ep. 9

Tips & Tricks for Percutaneous Nephrolithotomy (PCNL)

Dr. Margaret Pearle, the Vice Chair of Urology at UT Southwestern Medical Center, joins us to discuss percutaneous nephrolithotomy (PCNL).


Ep. 7

Bringing APPs Into Your Practice

Dr. Aditya Bagrodia and Dr. Jose E Silva interview Brad Hornberger, PA-C in the UTSW Urology department, about bringing advanced practice providers (APPs) into your practice, and how to do it successfully.


Ep. 6

Contemporary Surgical Management of BPH

In Part II, Dr. Aditya Bagrodia talks with Dr. Claus Roehrborn of UT Southwestern Medical Center about the surgical management of benign prostatic hyperplasia (BPH).


Ep. 5

Contemporary Medical Management of BPH

In Part I, Dr. Aditya Bagrodia talks with Dr. Claus Roehrborn of UT Southwestern Medical Center about the medical management of benign prostatic hyperplasia (BPH).


Ep. 3

Management of Testicular Cancer

Dr. Jose Silva talks with Urologist Dr. Aditya Bagrodia from UT Southwestern Medical Center about the medical and surgical management of testicular cancer.


Ep. 2

Management of Bladder Cancer

Dr. Jose Silva talks with Urologist Dr. Aditya Bagrodia from UT Southwestern Medical Center about the medical and surgical management of bladder cancer.


Articles Featuring Dr. Bagrodia

Testicular Cancer and Fertility After Orchiectomy

The testes are responsible for sperm production, so many patients have concerns about testicular cancer and fertility preservation after radical orchiectomy.

Young man consulting with his Urologist about testicular cancer and fertility after orchiectomy

MicroRNA Testing: The Latest in Testicular Cancer Markers

Testicular cancer markers are the first step in working up a testicular mass, but are not elevated in all testis cancers. MicroRNA biomarkers are elevated in roughly 90% of testis cancers.

Blood test for testicular cancer markers.

Using the IPSS to Evaluate BPH Symptoms

The International Prostate Symptom Score (IPSS) is a universal assessment endorsed by the AUA. The IPSS questionnaire consists of 7 questions and evaluates BPH patients from a score of 0 to 35.

Urologist using the IPPS to evaluate patient with BPH

Using 5-Alpha Reductase Inhibitors (5-ARIs) for BPH

5-alpha reductase inhibitors are a class of medications commonly used to treat BPH. They are most effective in BPH patients with large prostates.

5-alpha reductase inhibitors for BPH

HoLEP Procedure: Advantages & Limitations

The HoLEP procedure, or holmium laser enucleation of the prostate, is a new BPH treatment that is widely used because of its minimal invasiveness and quicker recovery times. However, urologists should evaluate the limitations of the HoLEP procedure before they decide on the procedure.

HoLEP procedure surgery

UroLift Procedure: Advantages and Limitations

The UroLift procedure is a minimally invasive, non-ablative BPH treatment that places permanent implants to pull the prostate lobes away from the urethra.

urolift procedure device

Bipolar TURP Procedure Advantages & Complications

The bipolar TURP procedure involves the use of a bipolar current to resect excess prostate tissue, alleviating symptoms in patients with benign prostate hyperplasia (BPH). Learn about Bipolar TURP procedure steps, advantages of the procedure, and complications.

bipolar turp procedure device

PCNL Procedure Techniques

Percutaneous nephrolithotomy (PCNL), a minimally invasive alternative to open kidney stone surgery, is a surgical technique that is used to remove large or complex kidney stones.

pcnl surgery kidney stone

PCNL Nephrostomy Tube Insertion & Management

Certain PCNL patients will require a nephrostomy tube, a catheter that drains urine from the kidney to an external bag.

nephrostomy tube placement

Tumor Thrombus & Budd Chiari Syndrome in Kidney Cancer

Tumor thrombus formation is common in locally advanced kidney cancer, and can lead to bland thrombus, pulmonary emboli, and even Budd-Chiari syndrome. The risk of pulmonary emboli creates unique challenges during kidney cancer surgery.

Renal cell carcinoma with tumor thrombus in the interior vena cava

Kidney Cancer Surgery: Nephrectomy, Lymph Node Dissection, When & Why

Kidney cancer surgery can be aggressive or conservative, depending on various factors. This article discusses when to perform a partial vs. radical nephrectomy, the indications for lymph node dissection, and the viability of a robotic approach.

Kidney cancer surgery, specifically, a nephrectomy.

Get Connected

Thank you for listening! If you have a question for Dr. Aditya Bagrodia about a topic that he's discussed on the BackTable Urology Podcast, you can get in touch with this form. Please note that our contributors lead busy lives and are not able to respond to every inquiry.

Thanks! Message sent.

More BackTable Contributors

No related content.

Dr. Francisco Gelpi on the BackTable Podcast

Dr. Francisco Gelpi


Benign Prostate Hyperplasia (BPH), Incontinence, GreenLight Laser Prostatectomy

Anish Parikh on the BackTable Podcast

Anish Parikh


Career Inspiration

Dr. Jose Silva on the BackTable Podcast

Dr. Jose Silva


Career Inspiration, Bladder Cancer, Testicular Cancer

Brad Hornberger, PA on the BackTable Podcast

Brad Hornberger, PA


Advanced Practice Providers (APPs), Staffing, Training

Dr. Steve Hudak on the BackTable Podcast

Dr. Steve Hudak


Incontinence, Post-Prostatectomy, Cystoscopy

Dr. Blake Johnson on the BackTable Podcast

Dr. Blake Johnson


Urology Residency, Urology Education

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

BackTable Urology Podcast Favicon


Tel: 318-820-1023

1023 Walnut St. Suite 100

Boulder,  Colorado  80302

  • YouTube
  • White Twitter Icon
  • White LinkedIn Icon
  • Instagram
  • White Facebook Icon

© 2021 by Backtable. All rights reserved.


Please review our Terms of Use.